|
NVAX Novavax Inc 1000694 |
| Balance Sheet |
|
Current Assets
|
$850,816,000.00 |
|
Assets
|
$1,043,162,000.00 |
|
Current Liabilities
|
$342,461,000.00 |
|
Liabilities
|
$1,187,924,000.00 |
|
Equity
|
$-144,762,000.00 |
|
Shares Out
|
164422575.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-32,423,000.00 |
|
Investing Cash Flow
|
$-28,361,000.00 |
| Market Analysis |
Market Cap
|
$1,223,303,958.00 |
|
Price
|
$7.42 |
|
PB
|
1.03 |
|
EPS
|
-0.06 |
|
PS
|
2.87 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:23 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:19 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
0.11 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-06 |
-0.06 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
0.62 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-1.25 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NVAX documents filed with the SEC.
NVAX Filings
Clear
